Home
/
Treatment
/
1′-{[5-(trifluoromethyl)-2-furyl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3′-indol]-2′(1’H)-one

1′-{[5-(trifluoromethyl)-2-furyl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3′-indol]-2′(1’H)-one

	1′-{[5-(trifluoromethyl)-2-furyl]methyl}spiro[furo[2,3-f][1,3]benzodioxole-7,3′-indol]-2′(1’H)-one
Trade Name
Orphan Indication	Erythromelalgia
USA Market Approval	USA
USA Designation Date	2012-11-19 00:00:00
Sponsor	Teva Pharmaceuticals;41 Moores Road, P. O. Box 4011;Frazer, Pennsylvania, 19355

Related Access Program

Johns Hopkins University – Anemia University of Miami – Anemia Children’s Hospital of Philadelphia – Leukemia Steven M. Frank, MD – Anemia Atara Biotherapeutics – Epstein-Barr Virus-Associated Viremia Spectral Diagnostics (US) Inc. – Endotoxemia Hospital Ana Nery – Thromboembolism